Skip to main content
Livermore
Livermore
ZHEN

Renaissance Technologies LLC

SEC CIK
0001037389
Latest filing
Aug 13, 2026

XERS holding history

Xeris Biopharma Holdings, Inc. in every 13F filed by Renaissance Technologies LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

XERS overviewAll 13F holders of XERSFull Q2 2026 holdings

Shares (Q2 2026)
67,337
Value
$533.3K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of XERS by Renaissance Technologies LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202667,337$533.3K<0.1%−385,523−85.1%ReducedHolders
Q1 2026452,860$2.63M<0.1%−166,800−26.9%ReducedHolders
Q4 2025619,660$4.86M<0.1%−1,003,180−61.8%ReducedHolders
Q3 20251,622,840$13.2M<0.1%−432,500−21.0%ReducedHolders
Q2 20252,055,340$9.60M<0.1%−107,300−5.0%ReducedHolders
Q1 20252,162,640$11.9M<0.1%+63,800+3.0%AddedHolders
Q4 20242,098,840$7.12M<0.1%+500,120+31.3%AddedHolders
Q3 20241,598,720$4.56M<0.1%+247,080+18.3%AddedHolders
Q2 20241,351,640$3.04M<0.1%+342,300+33.9%AddedHolders
Q1 20241,009,340$2.23M<0.1%−372,300−26.9%ReducedHolders
Q4 20231,381,640$3.25M<0.1%+359,600+35.2%AddedHolders
Q3 20231,022,040$1.90M<0.1%+163,346+19.0%AddedHolders
Q2 2023858,694$2.25M<0.1%+254,800+42.2%AddedHolders
Q1 2023603,894$984.0K<0.1%+105,400+21.1%AddedHolders
Q4 2022498,494$663.0K<0.1%−51,200−9.3%ReducedHolders
Q3 2022549,694$858.0K<0.1%−94,000−14.6%ReducedHolders
Q2 2022643,694$991.0K<0.1%−49,300−7.1%ReducedHolders
Q1 2022692,994$1.77M<0.1%−187,200−21.3%ReducedHolders
Q4 2021880,194$2.58M<0.1%+738,182+519.8%AddedHolders
Q3 2021142,012$348.0K<0.1%−1,094,583−88.5%ReducedHolders
Q2 20211,236,595$5.03M<0.1%+178,932+16.9%AddedHolders
Q1 20211,057,663$4.77M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.